JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB267788

Anti-Poliovirus Receptor/PVR antibody [EPR22672-151]

  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • What is this?

Be the first to review this product! Submit a review

|

(9 Publications)

Rabbit Recombinant Monoclonal Poliovirus Receptor/PVR antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 9 publications.

View Alternative Names

CD155, PVS, PVR, Poliovirus receptor, Nectin-like protein 5, NECL-5

7 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)

Immunohistochemical analysis of paraffin-embedded human colon cancer tissue labeling Poliovirus Receptor/PVR with ab267788 at 1/500 dilution (1.01μg/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining in human colon cancer (PMID : 28816021,11454801). Counterstained with hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Flow Cytometry - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)

Flow cytometric analysis of Raji (Human Burkitt's lymphoma B lymphocyte) (Left panel) and A549 (Human lung carcinoma epithelial cell) (Right panel) labeling Poliovirus Receptor/PVR with ab267788 at 1/50 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) / Black isotype control and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.

Negative control : Raji (PMID : 31500665).

Gated on viable cells.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)

Immunohistochemical analysis of paraffin-embedded human lung cancer tissue labeling Poliovirus Receptor/PVR with ab267788 at 1/500 dilution (1.01μg/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining in human lung cancer (PMID : 20331633). Counterstained with hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)

Immunohistochemical analysis of paraffin-embedded human breast cancer tissue labeling Poliovirus Receptor/PVR with ab267788 at 1/500 dilution (1.01μg/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining in human breast cancer (PMID : 31035013). Counterstained with hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Western blot - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)
  • WB

Unknown

Western blot - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)

Blocking and dilution buffer : 5% NFDM/TBST.

Exposure time : 3 minutes.

PVR/CD155 is a glycoprotein. The molecular weight observed is consistent with what has been described in the literature (PMID : 17893876,11454801).

This blot was developed using a higher sensitivity ECL substrate.

All lanes:

Western blot - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (ab267788) at 1/1000 dilution

Lane 1:

Human placenta lysate at 20 µg

Lane 2:

Human lung cancer lysate at 20 µg

Lane 3:

Human colon cancer lysate at 20 µg

Secondary

All lanes:

Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/2000 dilution

Predicted band size: 45 kDa

Observed band size: 70 kDa

false

Western blot - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)
  • WB

Unknown

Western blot - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)

Lanes 1- 4 : Merged signal (red and green). Green - ab267788 observed at 70 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab267788 was shown to react with Poliovirus Receptor/PVR in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266102 (knockout cell lysate ab257622) was used. Wild-type HEK-293T and PVR knockout HEK-293T cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab267788 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (ab267788) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

PVR knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human PVR (Poliovirus Receptor) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-pvr-poliovirus-receptor-knockout-hek-293t-cell-line-ab266102'>ab266102</a>)

Lane 3:

Wild-type A549 cell lysate at 20 µg

Lane 4:

PVR knockout A549 cell lysate at 20 µg

Predicted band size: 45 kDa

Observed band size: 70 kDa

false

Western blot - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)
  • WB

Unknown

Western blot - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (AB267788)

Blocking and dilution buffer : 5% NFDM/TBST.

Exposure time : 10 seconds.

Negative control : Raji (PMID : 28829151, 31500665).

PVR/CD155 is a glycoprotein. The molecular weight observed is consistent with what has been described in the literature (PMID : 17893876,11454801).

All lanes:

Western blot - Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] (ab267788) at 1/1000 dilution

Lane 1:

A549 (human lung carcinoma epithelial cell), whole cell lysate at 20 µg

Lane 2:

WI-38 (human fetal lung fibroblast), whole cell lysate at 20 µg

Lane 3:

HT-1080 (human fibrosarcoma epithelial cell), whole cell lysate at 20 µg

Lane 4:

U-87 MG (human glioblastoma-astrocytoma epithelial cell), whole cell lysate at 20 µg

Lane 5:

HUVEC (human umbilical vein endothelial cell), whole cell lysate at 20 µg

Lane 6:

Raji (human Burkitt's lymphoma B lymphocyte), whole cell lysate at 20 µg

Lane 7:

MCF7 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 45 kDa

Observed band size: 70 kDa

false

  • Carrier free

    Anti-Poliovirus Receptor/PVR antibody [EPR22672-151] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR22672-151

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

Flow Cyt, WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/50", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Poliovirus Receptor (PVR) also known as CD155 is a cell surface glycoprotein with a molecular mass of approximately 70 kDa. This receptor is expressed on a variety of cell types including epithelial and endothelial cells immune cells and fibroblasts. Another name for PVR is Necl-5 which falls under the nectin-like molecule family. It acts as an adhesion molecule and contributes to cellular signaling and junctional complexes. The expression of PVR is widespread across multiple tissues but it exhibits stronger expression in areas such as the skin and the gastrointestinal tract.
Biological function summary

The Poliovirus Receptor plays meaningful roles in immune response modulation and cell-cell adhesion. PVR interacts with components of the immune system and forms complexes with other proteins like CD226 and TIGIT. These interactions help regulate immune cell activities especially in the context of natural killer (NK) cells and T-cells. The CD155 protein also links to migration and proliferation processes which are essential for tissue formation and repair.

Pathways

PVR is involved in the regulation of immune and signaling pathways. It fits into pathways like NK cell activation and T-cell inhibitory signaling which are important for maintaining immune tolerance and preventing autoimmunity. In these pathways PVR interacts closely with other immunoregulatory proteins including CD226 and TIGIT. The partnership of PVR with these proteins shapes the delicate balance between immune activation and suppression demonstrating a clear role in immune homeostasis.

PVR relates to conditions such as cancer and viral infection. Its overexpression or altered signaling has been observed in several cancers where it may contribute to tumor growth and immune evasion. The interaction between PVR and its related protein TIGIT can affect antitumor immune responses complicating cancer progression. Additionally as its name suggests PVR binds to the poliovirus facilitating viral entry and spread during infection. This highlights the importance of PVR not only in pathogenic interactions but also in broader immune response contexts.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Mediates NK cell adhesion and triggers NK cell effector functions. Binds two different NK cell receptors : CD96 and CD226. These interactions accumulates at the cell-cell contact site, leading to the formation of a mature immunological synapse between NK cell and target cell. This may trigger adhesion and secretion of lytic granules and IFN-gamma and activate cytotoxicity of activated NK cells. May also promote NK cell-target cell modular exchange, and PVR transfer to the NK cell. This transfer is more important in some tumor cells expressing a lot of PVR, and may trigger fratricide NK cell activation, providing tumors with a mechanism of immunoevasion. Plays a role in mediating tumor cell invasion and migration.. (Microbial infection) Acts as a receptor for poliovirus. May play a role in axonal transport of poliovirus, by targeting virion-PVR-containing endocytic vesicles to the microtubular network through interaction with DYNLT1. This interaction would drive the virus-containing vesicle to the axonal retrograde transport.. (Microbial infection) Acts as a receptor for Pseudorabies virus.. (Microbial infection) Is prevented to reach cell surface upon infection by Human cytomegalovirus /HHV-5, presumably to escape immune recognition of infected cell by NK cells.
See full target information PVR

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Iranian journal of basic medical sciences 28:1344-1353 PubMed40896704

2025

Overexpression of miRNA-216 in exosomes derived from umbilical cord mesenchymal stem cells promotes angiogenesis and improves functional recovery after spinal cord injury.

Applications

Unspecified application

Species

Unspecified reactive species

Hengde Li,Renfeng Yi,Youbing Fan,Gonghao Zhan,Taoyuan Xiao

Journal of extracellular vesicles 14:e70078 PubMed40366616

2025

Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non-Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning.

Applications

Unspecified application

Species

Unspecified reactive species

Ye Yuan,Hai Jiang,Rui Xue,Xiao-Jun Feng,Bi-Feng Liu,Lian Li,Bo Peng,Chen-Shuo Ren,Shi-Min Li,Na Li,Min Li,Dian-Bing Wang,Xian-En Zhang

Biomolecules 15: PubMed40149859

2025

VPS25 Promotes an Immunosuppressive Microenvironment in Head and Neck Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Li-Guo Chen,Yu-Han Fang,Kui-Ming Wang,Wei Zhang,Gang Chen

Cell reports. Medicine 6:102024 PubMed40107247

2025

Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Tong Liu,Hai-Ming Liu,Jian-Gang Ren,Wei Zhang,Xin-Xin Wang,Zi-Li Yu,Qiu-Yun Fu,Xue-Peng Xiong,Jun Jia,Bing Liu,Gang Chen

International journal of molecular sciences 25: PubMed39596207

2024

SOCS1 Inhibits IL-6-Induced CD155 Overexpression in Lung Adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Mario Marroquin-Muciño,Jesus J Benito-Lopez,Mario Perez-Medina,Dolores Aguilar-Cazares,Miriam Galicia-Velasco,Rodolfo Chavez-Dominguez,Sergio E Meza-Toledo,Manuel Meneses-Flores,Angel Camarena,Jose S Lopez-Gonzalez

Frontiers in immunology 15:1373321 PubMed38596684

2024

IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via STAT3/CD155 signaling axis.

Applications

Unspecified application

Species

Unspecified reactive species

Junzhang Chen,Shiran Sun,Hui Li,Xiong Cai,Chidan Wan

Diagnostics (Basel, Switzerland) 12: PubMed36552960

2022

PVR-A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Wen-Feng Liu,Bing Quan,Miao Li,Feng Zhang,Ke-Shu Hu,Xin Yin

Discover. Oncology 13:53 PubMed35768666

2022

CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Huixian Xin,Yuchen Liu,Pengxiang Chen,Tianwen Yin,Meijie Wang,Tianyu Liu,Zhihua Wen,Yufeng Cheng

Cancer cell 39:1342-1360.e14 PubMed34358448

2021

The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

William A Freed-Pastor,Laurens J Lambert,Zackery A Ely,Nimisha B Pattada,Arjun Bhutkar,George Eng,Kim L Mercer,Ana P Garcia,Lin Lin,William M Rideout,William L Hwang,Jason M Schenkel,Alex M Jaeger,Roderick T Bronson,Peter M K Westcott,Tyler D Hether,Prajan Divakar,Jason W Reeves,Vikram Deshpande,Toni Delorey,Devan Phillips,Omer H Yilmaz,Aviv Regev,Tyler Jacks
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com